Similar biological medicinal products containing interferon beta

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMA/CHMP/BMWP/652000/2010
Effective from01/09/2013
KeywordsInterferon beta, similar biological medicinal product, biosimilar, comparability, non-clinical studies, clinical studies
DescriptionThis document lays down the non-clinical and clinical requirements for interferon beta (IFN-β) containing medicinal products claiming to be similar to another interferon beta already marketed.

Document history

First version

Current version

Adopted guideline

Overview of comments

Draft guideline

Concept paper

In operation: 01/09/2013–present

Published: 06/03/2013

Published: 19/01/2012

Published: 06/04/2010

Related content

How helpful is this page?

Average rating:

 Based on 26 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
6 ratings

Tell us more